ACLX
Price
$68.10
Change
+$1.85 (+2.79%)
Updated
Jun 6 closing price
Capitalization
3.65B
70 days until earnings call
ADMA
Price
$20.61
Change
+$0.67 (+3.36%)
Updated
Jun 6 closing price
Capitalization
4.76B
58 days until earnings call
Interact to see
Advertisement

ACLX vs ADMA

Header iconACLX vs ADMA Comparison
Open Charts ACLX vs ADMABanner chart's image
Arcellx
Price$68.10
Change+$1.85 (+2.79%)
Volume$595.32K
Capitalization3.65B
ADMA Biologics
Price$20.61
Change+$0.67 (+3.36%)
Volume$1.37M
Capitalization4.76B
ACLX vs ADMA Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. ADMA commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and ADMA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ACLX: $61.15 vs. ADMA: $19.51)
Brand notoriety: ACLX and ADMA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 48% vs. ADMA: 62%
Market capitalization -- ACLX: $3.65B vs. ADMA: $4.76B
ACLX [@Biotechnology] is valued at $3.65B. ADMA’s [@Biotechnology] market capitalization is $4.76B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileADMA’s FA Score has 2 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • ADMA’s FA Score: 2 green, 3 red.
According to our system of comparison, ADMA is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 5 TA indicator(s) are bullish while ADMA’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 5 bullish, 3 bearish.
  • ADMA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than ADMA.

Price Growth

ACLX (@Biotechnology) experienced а -6.70% price change this week, while ADMA (@Biotechnology) price change was -3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

ADMA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADMA($4.76B) has a higher market cap than ACLX($3.65B). ADMA YTD gains are higher at: 13.761 vs. ACLX (-20.263). ADMA has higher annual earnings (EBITDA): 148M vs. ACLX (-99.06M). ACLX has more cash in the bank: 587M vs. ADMA (103M). ACLX has less debt than ADMA: ACLX (54.1M) vs ADMA (82.1M). ADMA has higher revenues than ACLX: ADMA (426M) vs ACLX (108M).
ACLXADMAACLX / ADMA
Capitalization3.65B4.76B77%
EBITDA-99.06M148M-67%
Gain YTD-20.26313.761-147%
P/E RatioN/A23.74-
Revenue108M426M25%
Total Cash587M103M570%
Total Debt54.1M82.1M66%
FUNDAMENTALS RATINGS
ADMA: Fundamental Ratings
ADMA
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXADMA
RSI
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
85%
Bullish Trend 12 days ago
88%
Momentum
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
83%
MACD
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
88%
Bearish Trend 12 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
78%
Bearish Trend 12 days ago
76%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
Bullish Trend 20 days ago
87%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ADMA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-1.29%
CGON - ACLX
57%
Loosely correlated
-0.94%
KRYS - ACLX
56%
Loosely correlated
-2.44%
DNLI - ACLX
55%
Loosely correlated
-1.29%
KYMR - ACLX
54%
Loosely correlated
+2.35%
BEAM - ACLX
54%
Loosely correlated
-0.88%
More

ADMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADMA has been loosely correlated with TARS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ADMA jumps, then TARS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMA
1D Price
Change %
ADMA100%
-1.91%
TARS - ADMA
42%
Loosely correlated
+0.41%
IMTX - ADMA
40%
Loosely correlated
+4.26%
ACLX - ADMA
40%
Loosely correlated
-1.29%
ROIV - ADMA
39%
Loosely correlated
-1.30%
RCUS - ADMA
38%
Loosely correlated
+1.11%
More